Benjamin G Trist,Sian Genoud,Stéphane Roudeau,Alexander Rookyard,Amr Abdeen,Veronica Cottam,Dominic J Hare,Melanie White,Jens Altvater,Jennifer A Fifita,Alison Hogan,Natalie Grima,Ian P Blair,Kai Kysenius,Peter J Crouch,Asuncion Carmona,Yann Rufin,Stéphane Claverol,Stijn Van Malderen,Gerald Falkenberg,David J Paterson,Bradley Smith,Claire Troakes,Caroline Vance,Christopher E Shaw,Safa Al-Sarraj,Stuart Cordwell,Glenda Halliday,Richard Ortega,Kay L Double

Abstract:Abstract Aberrant self-assembly and toxicity of wild-type and mutant superoxide dismutase 1 (SOD1) has been widely examined in silico, in vitro and in transgenic animal models of amyotrophic lateral sclerosis. Detailed examination of the protein in disease-affected tissues from amyotrophic lateral sclerosis patients, however, remains scarce. We used histological, biochemical and analytical techniques to profile alterations to SOD1 protein deposition, subcellular localization, maturation and post-translational modification in post-mortem spinal cord tissues from amyotrophic lateral sclerosis cases and controls. Tissues were dissected into ventral and dorsal spinal cord grey matter to assess the specificity of alterations within regions of motor neuron degeneration. We provide evidence of the mislocalization and accumulation of structurally disordered, immature SOD1 protein conformers in spinal cord motor neurons of SOD1-linked and non-SOD1-linked familial amyotrophic lateral sclerosis cases, and sporadic amyotrophic lateral sclerosis cases, compared with control motor neurons. These changes were collectively associated with instability and mismetallation of enzymatically active SOD1 dimers, as well as alterations to SOD1 post-translational modifications and molecular chaperones governing SOD1 maturation. Atypical changes to SOD1 protein were largely restricted to regions of neurodegeneration in amyotrophic lateral sclerosis cases, and clearly differentiated all forms of amyotrophic lateral sclerosis from controls. Substantial heterogeneity in the presence of these changes was also observed between amyotrophic lateral sclerosis cases. Our data demonstrate that varying forms of SOD1 proteinopathy are a common feature of all forms of amyotrophic lateral sclerosis, and support the presence of one or more convergent biochemical pathways leading to SOD1 proteinopathy in amyotrophic lateral sclerosis. Most of these alterations are specific to regions of neurodegeneration, and may therefore constitute valid targets for therapeutic development.

A4T Mutation in the SOD1 Gene Causing Familial Amyotrophic Lateral Sclerosis

A Rare Cu/Zn Superoxide Dismutase Mutation Causing Familial Amyotrophic Lateral Sclerosis with Variable Age of Onset, Incomplete Penetrance and a Sensory Neuropathy

The G41D mutation in SOD1-related amyotrophic lateral sclerosis exhibits phenotypic heterogeneity among individuals: A case report and literature review

Identification of an A4V SOD1 mutation in a Chinese patient with amyotrophic lateral sclerosis without the A4V founder effect common in North America.

A Rare Cu/Zn Superoxide Dismutase Mutation Causing Familial Amyotrophic Lateral Sclerosis with Variable Age of Onset and Incomplete Penetrance in China.

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

An autopsy report of a long‐survival case of familial amyotrophic lateral sclerosis with SOD1 G93S gene mutation: Lack of SOD1‐positive inclusion in the remaining neurons

Clinical Features and Cu/Zn Superoxide Dismutase Gene Mutations in Two Mainland Chinese Families with Amyotrophic Lateral Sclerosis

A homozygous p.Val120Leu (c.358G > C) SOD1 mutation led to slowly progressive amyotrophic lateral sclerosis in a Brazilian family

Thirty-Year Follow-Up of Early Onset Amyotrophic Lateral Sclerosis with a Pathogenic Variant in SPTLC1

Missense Mutations of Codon 116 in the SOD1 Gene Cause Rapid Progressive Familial ALS and Predict Short Viability With PMA Phenotype

The genetics and neuropathology of amyotrophic lateral sclerosis

A novel 10-base pair insertion mutation in exon 5 of the SOD1 gene in a Chinese family with amyotrophic lateral sclerosis

The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration

A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration

Genotype-phenotype Correlations in a Chinese Population with Familial Amyotrophic Lateral Sclerosis.

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord

A Novel Mutation of VAPB in One Chinese Familial Amyotrophic Lateral Sclerosis Pedigree and Its Clinical Characteristics

Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.

Screening for TUBA4A mutations in a large Chinese cohort of patients with ALS: re-evaluating the pathogenesis of TUBA4A in ALS

Two Distinct Clinical Features and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients with TARDBP Gene Mutations in the Chinese Population